The nitroxide tempol has similar antioxidant effects as physiological levels of 17β-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 4, 2009, Pages 526-534

  Enli, Yasar ^a   Öztekin, Özer ^a   Pinarbasili, Raziye Didem ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Oestrogen; ovariectomy; oxidative stress; reactive oxygen species; tempol

Indexed keywords

CATALASE; ESTRADIOL; GLUTATHIONE; MYELOPEROXIDASE; NITROXIDE; SCAVENGER; SUPEROXIDE DISMUTASE; TEMPOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; KIDNEY PARENCHYMA; LIVER; MOUSE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; CATALASE; CYCLIC N-OXIDES; ESTRADIOL; FEMALE; GLUTATHIONE; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; OVARIECTOMY; OXIDATIVE STRESS; PEROXIDASE; SPIN LABELS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

MUS;

EID: 67651177696     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510902862967     Document Type: Article

References (43)

1. Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ H ealth Perspect. 1994;102:5-12.
2. Muthusami S, Ramachandran I, Muthusamy B, Vasudevan G, Prabhu V, Subramaniam V, Jagadeesan A, Narasimhan S. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta. 2005;360:81-6.
3. Dubey K, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol. 2001;280:365-88.
4. Shwaery GT, Vita JA, Keaney JF Jr. Antioxidant protection of LDL by physiological concentratons of 17β-estradiol. Requirement for estradiol modifi cation. Circulation. 1997;95:1378-85.
5. Miura T, Muraoka S, Ogiso T. Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids. 1996;61:379-83.
6. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuro-protection by estradiol. Prog Neurobiol. 2001;63:29-60.
7. Thiemermann C. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury and inflammation. Crit Care Med. 2003;31:76-84.
8. Sepodes B, Maio R, Pinto R, Marques C, Mendes-do-Vale J, McDonald MC, Thiemermann C, Mota-Filipe H. Tempol, an intracellular free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc. 2004;36:849-53.
9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-8.
10. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophys Acta. 1979;82:67-78.
11. Knight KR, Zhang B, Morrison WA, Stewart AG. Ischaemia-reperfusion injury in mouse skeletal muscle is reduced by N omega-nitro-L-arginine methyl ester and dexamethasone. Eur J Pharmacol. 1997;332:273-8.
12. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975;85:337-41.
13. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
14. Raafat AM, Hofseth LJ, Li S, Bennett JM, Halsam SZ. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice. Endocrinology. 1999;140:2570-80.
15. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 1998;58:617-21.
16. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet. 1999;353:571-80.
17. Harman SM. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med. 2006;3:254-69.
18. Arnal JF, Douin-Echinard V, Tremollières F, Terrisse AD, Sié P, Payrastre B, Guery JC, Bayard F, Gourdy P. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis. Arch Mal Coeur Vaiss. 2007;100:554-62.
19. Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol. 2007;27:1782-7.
20. Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW, He JH, Yao DF. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol. 2007;13:4295-305.
21. Codes L, Matos L, Paraná R. Chronic hepatitis C and fi brosis: evidences for possible estrogen benefits. Braz J Infect Dis. 2007;11:371-4.
22. Weisinger JR, Bellorin-Font E. Postmenopausal osteoporosis in the dialysis patient. Curr Opin Nephrol Hypertens. 2003;12:381-6.
23. Kankofer M, Radzki RP, Bienko M, Albera E. Anti-oxidative/oxidative status of rat liver after ovariectomy. J Vet Med A Physiol Pathol Clin Med. 2007;54:225-9.
24. Lu G, Shimizu I, Cui X, Itonaga M, Tamaki K, Fukuno H, Inoue H, Honda H, Ito S. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fi brosis in rats. Life Sci. 2004;74:897-907.
25. Seçkin S, Dogru-Abbasoglu S, Basaran-Küçükgergin C, Yavu E, Cevikbas U, Aykaç-Toker G, Uysal M. Increased lipid peroxidation in the liver and kidney and their mitochondrial fractions following buthionine sulfoximine induced glutathione depletion in guinea pigs. Res Commun Mol Pathol Pharmacol. 2001;109:299-308.
26. Ha BJ. Oxidative stress in ovariectomy menopause and role of chondroitin sulfate. Arch Pharm Res. 2004;27:867-72.
27. Terman A, Gustafsson B, Brunk UT. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact. 2006;163:29-37.
28. Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest. 1993;91:2866-72.
29. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Simpkins J W. Quinol-based metabolic cycle for estrogens in rat liver microsomes. Drug Metab Dispos. 2003;31:701-4.
30. Ueda A, Nagase S, Yokoyama H, Tada M, Noda H, Ohya H, Kamada H, Hirayama A, Koyama A. Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol Cell Biochem. 2003;244:119-24.
31. Sepodes B, Maio R, Pinto R, Marques C, Mendes-do-Vale J, McDonald MC, Thiemermann C, Mota-Filipe H. Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc. 2004;36:849-53.
32. Blonder JM, McCalden TA, Hsia CJ, Billings RE. Polynitroxyl albumin plus tempol attenuates liver injury and inflammation after hepatic ischemia and reperfusion. Life Sci. 2000;67:3231-9.
33. Magness RR, Phernetton TM, Zheng J. Systemic and uterine blood flow distribution during prolonged infusion of 17beta-estradiol. Am J Physiol. 1998;275:731-43.
34. Dubey RK, Tyurina YY, Tyurin VA, Gillespie DG, Branch RA, Jackson EK, Kagan VE. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ Res. 1999;84:229-39.
35. Keaney JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17β-Estradiol preserves endothelial vasodilator function and limits LDL oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-9.
36. Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MHC. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension. 2002;39:405-11.
37. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, Vina J. 17β-Oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkB cascade. Aging Cell. 2005;4:113-18.
38. Bednarek-Tupikowaska G, Tupikowski K, Bidzinka B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B, Milewicz A. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol. 2004;19:57-63.
39. Ke RW, Pace DT, Ahpkas RA. Effect of hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil Steril. 2003;79:1118-22.
40. Unfer TC, Conterato GM, Da Silva JC, Duarte MM, Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta. 2006;369:73-7.
41. Bureau I, Laporte F, Favier M, Faure H, Fields M, Favier AE, Roussel AM. No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr. 2002;21:333-8.
42. Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res. 2004;10:6411-17.
43. Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB. Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res. 2007;13:4928-33.